Your session is about to expire
← Back to Search
Telenursing for Pulmonary Fibrosis
N/A
Waitlist Available
Led By Lisa Lancaster, MD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 21 months
Awards & highlights
Study Summary
This trial will test if structured telenursing with non-invasive home monitoring can improve outcomes for patients with IPF.
Who is the study for?
This trial is for newly diagnosed IPF patients who are willing to complete quality of life surveys, participate in remote calls with a nurse, and monitor daily health if required. They must have been diagnosed according to specific guidelines and started treatment within 6 months if not at VUMC.Check my eligibility
What is being tested?
The study tests whether structured telenursing combined with home monitoring can reduce hospital visits, improve adherence to treatments, and enhance the quality of life for IPF patients compared to usual care.See study design
What are the potential side effects?
Since this trial involves non-invasive monitoring and communication rather than medication or invasive procedures, there are no direct side effects associated with the interventions being tested.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 21 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 21 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The Number Hospitalization Events Resulting From a Respiratory Illness
Secondary outcome measures
The Number of Acute Exacerbations of Idiopathic Pulmonary Fibrosis (IPF)
The Number of Days From Idiopathic Pulmonary Fibrosis (IPF) Diagnosis to First Hospitalization for Respiratory Illness
The Number of Respiratory Events That Indicate a Worsening of Idiopathic Pulmonary Fibrosis (IPF)
+4 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Telenursing and Remote MonitoringExperimental Treatment3 Interventions
Patients will receive usual care with telenursing and will be given a hand held spirometer and puse oximeter and be asked to take daily measurements and report these via an electronic HIPAA approved secured platform for evaluation by the telenursing team.
Group II: TelenursingExperimental Treatment2 Interventions
Patients will receive usual care with structured phone calls from the nurse practitioner and/or case manager occuring more frequently earlier in the diagnosis to help the patient and care giver understand all aspects of the disease and it time will evolve to managing symptoms outside of out-patient clinic visits.
Group III: Usual Care of IPFActive Control1 Intervention
Newly diagnosed patients will continue to receive excellent healthcare as currently given in management of the lung disease
Find a Location
Who is running the clinical trial?
Vanderbilt University Medical CenterLead Sponsor
856 Previous Clinical Trials
672,126 Total Patients Enrolled
2 Trials studying Idiopathic Pulmonary Fibrosis
781 Patients Enrolled for Idiopathic Pulmonary Fibrosis
Lisa Lancaster, MDPrincipal InvestigatorVanderbilt University Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You must have been recently diagnosed with IPF by a specific doctor at Vanderbilt University Medical Center, or have started treatment within 6 months of being diagnosed by your local doctor.You have been diagnosed with a type of lung disease other than the one being studied.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care of IPF
- Group 2: Telenursing and Remote Monitoring
- Group 3: Telenursing
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities to enroll in this research project at the moment?
"Clinicaltrials.gov information shows that this particular medical experiment is not presently enrolling participants; its initial post was on August 1st 2018 and it was last updated on February 3rd 2021. Despite this, 414 other clinical trials are currently looking for patients to take part in their research."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger